Literature DB >> 18194747

The spectrum of diabetic neuropathies.

Jennifer A Tracy1, P James B Dyck.   

Abstract

Diabetes mellitus is associated with many different neuropathic syndromes, ranging from a mild sensory disturbance as can be seen in a diabetic sensorimotor polyneuropathy, to the debilitating pain and weakness of a diabetic lumbosacral radiculoplexus neuropathy. The etiology of these syndromes has been studied extensively, and may vary among metabolic, compressive, and immunological bases for the different disorders, as well as mechanisms yet to be discovered. Many of these disorders of nerve appear to be separate conditions with different underlying mechanisms, and some are caused directly by diabetes mellitus, whereas others are associated with it but not caused by hyperglycemia. This article discusses a number of the more common disorders of nerve found with diabetes mellitus. It discusses the symmetrical neuropathies, particularly generalized diabetic polyneuropathy, and then the focal or asymmetrical types of diabetes-associated neuropathy.

Entities:  

Mesh:

Year:  2008        PMID: 18194747      PMCID: PMC2720624          DOI: 10.1016/j.pmr.2007.10.010

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  72 in total

1.  Epineurial microvasculitis in proximal diabetic neuropathy.

Authors:  J G Llewelyn; P K Thomas; R H King
Journal:  J Neurol       Date:  1998-03       Impact factor: 4.849

2.  Unilateral abdominal muscle herniation with pain: a distinctive variant of diabetic radiculopathy.

Authors:  K R Chaudhuri; D R Wren; D Werring; P J Watkins
Journal:  Diabet Med       Date:  1997-09       Impact factor: 4.359

3.  Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994.

Authors:  M I Harris; K M Flegal; C C Cowie; M S Eberhardt; D E Goldstein; R R Little; H M Wiedmeyer; D D Byrd-Holt
Journal:  Diabetes Care       Date:  1998-04       Impact factor: 19.112

4.  Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: A randomized controlled trial. rhNGF Clinical Investigator Group.

Authors:  S C Apfel; S Schwartz; B T Adornato; R Freeman; V Biton; M Rendell; A Vinik; M Giuliani; J C Stevens; R Barbano; P J Dyck
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

5.  Diabetic thoracic polyradiculopathy: ten patients with abdominal pain.

Authors:  G F Longstreth
Journal:  Am J Gastroenterol       Date:  1997-03       Impact factor: 10.864

6.  Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980-1985 World Health Organization diagnostic criteria.

Authors:  M I Harris; R C Eastman; C C Cowie; K M Flegal; M S Eberhardt
Journal:  Diabetes Care       Date:  1997-12       Impact factor: 19.112

7.  Subacute diabetic proximal neuropathy.

Authors:  M K Pascoe; P A Low; A J Windebank; W J Litchy
Journal:  Mayo Clin Proc       Date:  1997-12       Impact factor: 7.616

8.  Distinctive pathologic findings in proximal diabetic neuropathy (diabetic amyotrophy).

Authors:  P Kelkar; M Masood; G J Parry
Journal:  Neurology       Date:  2000-07-12       Impact factor: 9.910

Review 9.  Pathologic alterations in the diabetic neuropathies of humans: a review.

Authors:  P J Dyck; C Giannini
Journal:  J Neuropathol Exp Neurol       Date:  1996-12       Impact factor: 3.685

10.  Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. NGF Study Group.

Authors:  S C Apfel; J A Kessler; B T Adornato; W J Litchy; C Sanders; C A Rask
Journal:  Neurology       Date:  1998-09       Impact factor: 9.910

View more
  28 in total

1.  Pharmacological treatment of diabetic peripheral neuropathy.

Authors:  Kenneth Cohen; Nataliya Shinkazh; Jerry Frank; Igor Israel; Chris Fellner
Journal:  P T       Date:  2015-06

2.  Emergency Neurological Life Support: Acute Non-traumatic Weakness.

Authors:  Anna Finley Caulfield; Oliver Flower; Jose A Pineda; Shahana Uddin
Journal:  Neurocrit Care       Date:  2017-09       Impact factor: 3.210

3.  Comprehensive Review of the Effects of Diabetes on Ocular Health.

Authors:  Kathryn Skarbez; Yos Priestley; Marcia Hoepf; Steven B Koevary
Journal:  Expert Rev Ophthalmol       Date:  2010-08-01

4.  Ambulatory screening of diabetic neuropathy and predictors of its severity in outpatient settings.

Authors:  M S Qureshi; M Iqbal; S Zahoor; J Ali; M U Javed
Journal:  J Endocrinol Invest       Date:  2016-11-15       Impact factor: 4.256

5.  Prevalence, severity and factors associated with peripheral neuropathy among newly diagnosed diabetic patients attending Mulago hospital: a cross-sectional study.

Authors:  Twaha Kisozi; Edris Mutebi; Musubire Kisekka; Samden Lhatoo; Martha Sajatovic; Mark Kaddumukasa; Fredrick Nelson Nakwagala; Elly Katabira
Journal:  Afr Health Sci       Date:  2017-06       Impact factor: 0.927

Review 6.  Mechanisms of distal axonal degeneration in peripheral neuropathies.

Authors:  Christopher R Cashman; Ahmet Höke
Journal:  Neurosci Lett       Date:  2015-01-21       Impact factor: 3.046

Review 7.  Obesity and vulnerability of the CNS.

Authors:  Annadora J Bruce-Keller; Jeffrey N Keller; Christopher D Morrison
Journal:  Biochim Biophys Acta       Date:  2008-10-17

8.  Anti-inflammatory effect of AMPK signaling pathway in rat model of diabetic neuropathy.

Authors:  Amin Hasanvand; Hossein Amini-Khoei; Mohammad-Reza Hadian; Alireza Abdollahi; Seyed Mohammad Tavangar; Ahmad Reza Dehpour; Elika Semiei; Shahram Ejtemaei Mehr
Journal:  Inflammopharmacology       Date:  2016-08-09       Impact factor: 4.473

Review 9.  Spectrum of diabetic neuropathies.

Authors:  Hideyuki Sasaki; Nobutoshi Kawamura; Peter J Dyck; P James B Dyck; Mikihiro Kihara; Phillip A Low
Journal:  Diabetol Int       Date:  2020-01-08

10.  Diabetic amyotrophy, not your typical back pain.

Authors:  Jonathan Seung Doe Na; Philip C Dittmar
Journal:  BMJ Case Rep       Date:  2020-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.